WallStreetZenWallStreetZen

NASDAQ: PYXS
Pyxis Oncology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for PYXS

Based on 4 analysts offering 12 month price targets for Pyxis Oncology Inc.
Min Forecast
$7.00+68.27%
Avg Forecast
$8.50+104.33%
Max Forecast
$12.00+188.46%

Should I buy or sell PYXS stock?

Based on 4 analysts offering ratings for Pyxis Oncology Inc.
Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PYXS stock forecasts and price targets.

PYXS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-03-22
lockedlocked$00.00+00.00%2024-02-09
lockedlocked$00.00+00.00%2024-01-23

1 of 1

Forecast return on equity

Is PYXS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is PYXS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PYXS revenue forecast

What is PYXS's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$5.0M
Avg 2 year Forecast
$2.0M
Avg 3 year Forecast
$2.0M

PYXS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PYXS$4.16$8.50+104.33%Strong Buy
ADAP$0.98N/AN/A
PBYI$5.01$7.00+39.72%Buy
XERS$1.74$5.00+187.36%Strong Buy
XBIT$8.04N/AN/A
View Top Biotech Stocks

Pyxis Oncology Stock Forecast FAQ

Is Pyxis Oncology Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: PYXS) stock is to Strong Buy PYXS stock.

Out of 4 analysts, 1 (25%) are recommending PYXS as a Strong Buy, 3 (75%) are recommending PYXS as a Buy, 0 (0%) are recommending PYXS as a Hold, 0 (0%) are recommending PYXS as a Sell, and 0 (0%) are recommending PYXS as a Strong Sell.

If you're new to stock investing, here's how to buy Pyxis Oncology stock.

What is PYXS's revenue growth forecast for 2024-2026?

(NASDAQ: PYXS) Pyxis Oncology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Pyxis Oncology's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast PYXS's revenue for 2024 to be $290,666,875, with the lowest PYXS revenue forecast at $116,266,750, and the highest PYXS revenue forecast at $465,067,000. On average, 1 Wall Street analysts forecast PYXS's revenue for 2025 to be $116,266,750, with the lowest PYXS revenue forecast at $116,266,750, and the highest PYXS revenue forecast at $116,266,750.

In 2026, PYXS is forecast to generate $116,266,750 in revenue, with the lowest revenue forecast at $116,266,750 and the highest revenue forecast at $116,266,750.

What is PYXS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PYXS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is PYXS's Price Target?

According to 4 Wall Street analysts that have issued a 1 year PYXS price target, the average PYXS price target is $8.50, with the highest PYXS stock price forecast at $12.00 and the lowest PYXS stock price forecast at $7.00.

On average, Wall Street analysts predict that Pyxis Oncology's share price could reach $8.50 by Apr 10, 2025. The average Pyxis Oncology stock price prediction forecasts a potential upside of 104.33% from the current PYXS share price of $4.16.

What is PYXS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PYXS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.